News Neuren Pharmaceuticals Limited

Equities

NEU

NZNEUE0001S8

Market Closed - Australian S.E. Other stock markets 02:10:55 2024-04-23 am EDT			5-day change	1st Jan Change
19.3 ^AUD	+0.10%		-0.77%	-22.71%

03:34am	Neuren Pharmaceuticals' Medication Secures Priority Review from Health Canada	MT
Feb. 29	Neuren Pharmaceuticals Limited Provides Sales Guidance for the First Quarter and Full Year 2024	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Neuren Pharmaceuticals' Medication Secures Priority Review from Health Canada	09:34pm	MT
Weekly Top Ten News Stories - 15 March 2024	Mar. 15	AQ
Neuren Pharmaceuticals Limited Provides Sales Guidance for the First Quarter and Full Year 2024	Feb. 29	CI
Transcript : Neuren Pharmaceuticals Limited, Q4 2023 Earnings Call, Feb 29, 2024	Feb. 29
Neuren Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 28	CI
Culper Research discloses short position in Acadia Pharma	Feb. 15	RE
Neuren Pharmaceuticals Completes Recruitment for Phase Two Neurological Trial; Shares Fall 4%	Dec. 19	MT
Neuren Pharmaceuticals Concludes Enrollment for Phase 2 Trial in Pitt Hopkins Syndrome	Dec. 04	MT
Argenica Therapeutics Appoints Nonexecutive Chair	Nov. 29	MT
Neuren Pharmaceuticals Posts Higher Q3 Net Sales in US for Rett Syndrome Treatment	Nov. 03	MT
Fragile X Syndrome Pipeline, Clinical Trials Studies, Agreements & Collaborations, and Latest News 2023 (Updated)	23-10-10	AQ
Fragile X Syndrome Pipeline, Clinical Trials and NDA Approvals 2023 (Updated)	23-09-18	AQ
Neuren Pharmaceuticals Limited(ASX:NEU) added to S&P/ASX 200 Index	23-09-18	CI
Neuren Pharmaceuticals Limited Reiterates Net Sales Guidance for the Third Quarter of 2023	23-08-27	CI
Neuren Pharmaceuticals Limited Reports Earnings Results for the Half Year Ended June 30, 2023	23-08-27	CI
Sector Update: Health Care Stocks Gain Pre-Bell Friday	23-07-14	MT
Sector Update: Health Care	23-07-14	MT
Top Premarket Gainers	23-07-14	MT
ACADIA Pharma Acquires Ex-North America Rights to Trofinetide, Global Rights to NNZ-2591; Shares Surge Premarket	23-07-14	MT
Weaker-than-Expected US Data Spur Rally in Australian Shares	23-07-14	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Neuren Pharmaceuticals Limited

Equities

NEU

NZNEUE0001S8

Summary

Filters